Last reviewed · How we verify
NCT06164015: 3D-ARM
3D Ultrasound to Assess in Recurrent Miscarriage
trial testing 3D Ultrasound scan with power Doppler angiography in Recurrent Miscarriage in 400 participants. Status unknown.
31 December 2025
Quick facts
| Lead sponsor | University Hospitals of Derby and Burton NHS Foundation Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 December 2023 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
Drugs / interventions tested
- 3D Ultrasound scan with power Doppler angiography
Conditions studied
- Recurrent Miscarriage — all drugs for Recurrent Miscarriage →
Sponsor
University Hospitals of Derby and Burton NHS Foundation Trust
Who can join
Adults 18 to 40, female only, with Recurrent Miscarriage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study aims to compare the prevalence of acquired abnormalities of the uterus (fibroids, polyps, intrauterine adhesions, adenomyosis) in women who have recurrent miscarriages with the fertile population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06164015
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Recurrent Miscarriage
Currently open trials in the same condition.
- NCT06826365 — Immune Cell Populations in the Endometrium · recruiting
- NCT06356792 — Obstetrics , Prenatal Outcomes in Recurrent Miscarriage · recruiting
- NCT06163092 — Chronic Endometritis and Benefits of Antibiotics in Women With Recurrent Miscarriage · recruiting
- NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting
- NCT03902912 — Effect of Prednisolone Treatment on Uterine Natural Killer Cells · Phase 3 · recruiting
Other University Hospitals of Derby and Burton NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07377500 — Dialysate Cooling for the Preservation of Cognitive Function in People Receiving Haemodialysis · NA · not yet recruiting
- NCT07205692 — Multimorbidity and Cardiovascular Risk Factors After Renal Transplant · recruiting
- NCT06109662 — Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease · active not recruiting
- NCT06259305 — Memories in Heartbeats Study · NA · completed
- NCT06284044 — Facilitating Safe Transition to Home for Preterm Infants - a National Database Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06164015 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospitals of Derby and Burton NHS Foundation Trust
- Last refreshed: 11 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06164015.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing